Clinical trials
Phase 2 Carcinoma, Transitional Cell trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 3 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
| Incyte Corporation | 2 |
| Acrotech Biopharma Inc. | 1 |
| Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 1 |
| Bristol-Myers Squibb | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Genentech, Inc. | 1 |
| Nektar Therapeutics | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Universitair Ziekenhuis Brussel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 13 |
| Urinary Bladder Neoplasms | 5 |
| Neoplasm Metastasis | 3 |
| Acrocephalosyndactylia | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.